IPP Bureau
Covaxin shelf-life extended to 12 months from the date of manufacture
By IPP Bureau - November 03, 2021
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
WHO issues emergency use listing for Covaxin
By IPP Bureau - November 03, 2021
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia
By IPP Bureau - November 02, 2021
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
Thermo Fisher Scientific realigns product portfolio
By IPP Bureau - November 02, 2021
Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
By IPP Bureau - November 02, 2021
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
Built-for-purpose offering for biomolecule attribute monitoring
By IPP Bureau - November 02, 2021
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
By IPP Bureau - November 02, 2021
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
Caplin Point Labs posts Q2FY22 PAT at Rs 74.98 Cr
By IPP Bureau - November 02, 2021
The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr
By IPP Bureau - November 01, 2021
Lyka Labs has reported consolidated financial results for the period ended September 30, 2021
GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr
By IPP Bureau - November 01, 2021
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr
By IPP Bureau - November 01, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
Dr. Reddy's launches Ephedrine Sulfate injection in the US
By IPP Bureau - November 01, 2021
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
Glamyo Health widens its dental treatment portfolio
By IPP Bureau - November 01, 2021
Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth
EMA encourages companies to submit type I variations by end- November
By IPP Bureau - November 01, 2021
Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays
By IPP Bureau - November 01, 2021
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
